Skip to content

Clinical trials

Triple Negative Breast Neoplasms trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Triple Negative Breast Neoplasms Country / region: Israel Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20162
20172
20184
20196
20204
20214
20224
20231
20243
20256

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting11
Completed9
Active, not recruiting7
Terminated7
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC8
Novartis Pharmaceuticals7
AbbVie4
Hoffmann-La Roche3
Bristol-Myers Squibb2
Gilead Sciences2
Amgen1
Ayala Pharmaceuticals, Inc,1
BeiGene1
Dr. Ronnie Shapira1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Triple Negative Breast Neoplasms36
Carcinoma, Non-Small-Cell Lung11
Breast Neoplasms9
Squamous Cell Carcinoma of Head and Neck9
Ovarian Neoplasms7
Colorectal Neoplasms5
Melanoma5
Neoplasms5
Carcinoma, Hepatocellular4
Carcinoma, Renal Cell4

Trials

Showing 76 to 36 of 36. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.